Long-term safety of azathioprine for treatment of neuromyelitis optica spectrum disorders.
Ana Beatriz Ayroza Galvão Ribeiro GomesMilena Sales PitombeiraDouglas Kazutoshi SatoDagoberto CallegaroSamira Luisa Dos Apóstolos PereiraPublished in: Arquivos de neuro-psiquiatria (2021)
Azathioprine may be considered a safe agent for long-term treatment (>10 years) of NMOSD, but continuous vigilance for infections and malignancies is required.
Keyphrases